Tenet Healthcare Corporation (BIT:1THC)
Italy
· Delayed Price · Currency is EUR 191.00
0.00 (0.00%)
At close: Mar 2, 2026
Tenet Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 21,310 | 20,675 | 20,564 | 19,174 | 19,485 | Upgrade
|
| Revenue Growth (YoY) | 3.07% | 0.54% | 7.25% | -1.60% | 10.46% | Upgrade
|
| Cost of Revenue | 12,493 | 12,456 | 12,743 | 12,126 | 12,217 | Upgrade
|
| Gross Profit | 8,817 | 8,219 | 7,821 | 7,048 | 7,268 | Upgrade
|
| Selling, General & Admin | 410 | 417 | 418 | 412 | 412 | Upgrade
|
| Other Operating Expenses | 3,772 | 3,766 | 3,728 | 3,310 | 3,439 | Upgrade
|
| Operating Expenses | 5,045 | 5,001 | 5,016 | 4,563 | 4,706 | Upgrade
|
| Operating Income | 3,772 | 3,218 | 2,805 | 2,485 | 2,562 | Upgrade
|
| Interest Expense | -821 | -826 | -901 | -890 | -923 | Upgrade
|
| Earnings From Equity Investments | 264 | 260 | 228 | 216 | 218 | Upgrade
|
| Other Non Operating Income (Expenses) | 125 | 134 | 26 | 20 | 25 | Upgrade
|
| EBT Excluding Unusual Items | 3,340 | 2,786 | 2,158 | 1,831 | 1,882 | Upgrade
|
| Merger & Restructuring Charges | -69 | -95 | -94 | -132 | -77 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1 | 2,916 | 23 | 1 | 445 | Upgrade
|
| Asset Writedown | -61 | -7 | -43 | -94 | -8 | Upgrade
|
| Legal Settlements | -64 | -35 | -47 | -70 | -116 | Upgrade
|
| Other Unusual Items | -345 | -317 | -380 | -191 | -238 | Upgrade
|
| Pretax Income | 2,800 | 5,248 | 1,617 | 1,345 | 1,888 | Upgrade
|
| Income Tax Expense | 433 | 1,184 | 306 | 344 | 411 | Upgrade
|
| Earnings From Continuing Operations | 2,367 | 4,064 | 1,311 | 1,001 | 1,477 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -1 | Upgrade
|
| Net Income to Company | 2,367 | 4,064 | 1,311 | 1,001 | 1,476 | Upgrade
|
| Minority Interest in Earnings | -960 | -864 | -700 | -590 | -562 | Upgrade
|
| Net Income | 1,407 | 3,200 | 611 | 411 | 914 | Upgrade
|
| Net Income to Common | 1,407 | 3,200 | 611 | 411 | 914 | Upgrade
|
| Net Income Growth | -56.03% | 423.73% | 48.66% | -55.03% | 129.07% | Upgrade
|
| Shares Outstanding (Basic) | 90 | 97 | 102 | 107 | 107 | Upgrade
|
| Shares Outstanding (Diluted) | 91 | 98 | 105 | 111 | 109 | Upgrade
|
| Shares Change (YoY) | -7.20% | -6.60% | -5.17% | 1.79% | 2.17% | Upgrade
|
| EPS (Basic) | 15.61 | 33.02 | 6.01 | 3.84 | 8.56 | Upgrade
|
| EPS (Diluted) | 15.49 | 32.70 | 5.71 | 3.78 | 8.42 | Upgrade
|
| EPS Growth | -52.63% | 473.12% | 50.87% | -55.07% | 124.49% | Upgrade
|
| Free Cash Flow | 2,530 | 1,116 | 1,623 | 321 | 910 | Upgrade
|
| Free Cash Flow Per Share | 27.85 | 11.40 | 15.49 | 2.90 | 8.38 | Upgrade
|
| Gross Margin | 41.38% | 39.75% | 38.03% | 36.76% | 37.30% | Upgrade
|
| Operating Margin | 17.70% | 15.57% | 13.64% | 12.96% | 13.15% | Upgrade
|
| Profit Margin | 6.60% | 15.48% | 2.97% | 2.14% | 4.69% | Upgrade
|
| Free Cash Flow Margin | 11.87% | 5.40% | 7.89% | 1.67% | 4.67% | Upgrade
|
| EBITDA | 4,635 | 4,036 | 3,675 | 3,326 | 3,417 | Upgrade
|
| EBITDA Margin | 21.75% | 19.52% | 17.87% | 17.35% | 17.54% | Upgrade
|
| D&A For EBITDA | 863 | 818 | 870 | 841 | 855 | Upgrade
|
| EBIT | 3,772 | 3,218 | 2,805 | 2,485 | 2,562 | Upgrade
|
| EBIT Margin | 17.70% | 15.57% | 13.64% | 12.96% | 13.15% | Upgrade
|
| Effective Tax Rate | 15.46% | 22.56% | 18.92% | 25.58% | 21.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.